Results 21 to 30 of about 49,152 (197)
ObjectiveThis study aimed to describe a case of glomerulosclerosis resulting in nephrotic syndrome following the administration of pamidronate disodium to treat clinical calcitriol toxicity in a dog.Case summaryA 12-week-old intact male Labrador ...
Katherine Ann Dawson +2 more
doaj +1 more source
Treatment of experimental renal osteodystrophy with pamidronate [PDF]
We evaluated the effects of the bisphosphonate pamidronate on bone histomorphometry, structure and strength in male rats with uninephrectomy or with chronic renal disease induced by 5/6 nephrectomy.
Jokihaara, Jarkko +10 more
core +1 more source
Neurofibromatosis type 1 (NF1) is a commonly occurring genetic disorder in children. Mutation in the NF1 gene has its implication in poor osteoblastic capabilities.
Vrisha Madhuri +4 more
doaj +1 more source
Effectiveness and safety of pamidronate treatment in nonambulatory children with low bone mineral density [PDF]
Purpose Nonambulatory pediatric patients may have low bone mineral density (BMD) and increased risk of pathologic fractures. Though bisphosphonate therapy is the mainstream medical intervention in these children, clinical data regarding this treatment ...
Myeongseob Lee +7 more
doaj +1 more source
Background/Aims: The aim of this study was to evaluate the influence of pamidronate on ventricular remodeling after myocardial infarction. Methods: Male Wistar rats were assigned to four groups: a sham group, in which animals were submitted to simulated ...
Andréa F. Gonçalves +15 more
doaj +1 more source
PURPOSE AND PATIENTS: During the period from January 1990 to January 1996 a total of 953 patients with lymph node negative primary breast cancer were randomised to oral pamidronate (n=460) 150 mg twice daily for 4 years or no adjuvant pamidronate (n=493)
Ejlertsen, B. +12 more
core +3 more sources
Complications of pamidronate therapy in paediatric osteoporosis
Purpose Pamidronate, used for the treatment of paediatric osteoporosis, reduces the fracture rate and improves ambulatory status. Intravenous pamidronate therapy has known complications which have not been stratified based on its dose and distribution ...
Sanjay K. Chilbule, Vrisha Madhuri
doaj +1 more source
Not only has pamidronate been shown to prevent inflammation associated bone resorption following burn injury, it also reduces protein breakdown in muscle.
Fabrizio Pin +10 more
doaj +1 more source
Metaphyseal bands in osteogenesis imperfecta
An increasing number of patients with osteogenesis imperfecta are undergoing pamidronate therapy to prevent the incidence of fragility fractures. The authors herein report a child aged 3 years who received five cycles of pamidronate, resulting in ...
Suresh S, Thomas John
doaj +3 more sources
Osteoporosis is a major complication of chronic cholestatic liver disease (CCLD). We evaluated the efficacy of using disodium pamidronate (1.0 mg/kg body weight) for the prevention (Pr) or treatment (Tr) of cholestasis-induced osteoporosis in male Wistar
F.A. Pereira +7 more
doaj +2 more sources

